
Umamaheswari Ramachandran
Examiner (ID: 19568, Phone: (571)272-9926 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617 |
| Total Applications | 1600 |
| Issued Applications | 704 |
| Pending Applications | 154 |
| Abandoned Applications | 762 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20156924
[patent_doc_number] => 12383522
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-12
[patent_title] => Baclofen formulations and methods of minimizing patient exposure to metabolite variations
[patent_app_type] => utility
[patent_app_number] => 18/508830
[patent_app_country] => US
[patent_app_date] => 2023-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14521
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18508830
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/508830 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | Nov 13, 2023 | Issued |
Array
(
[id] => 20106945
[patent_doc_number] => 12357643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Emulsion formulations
[patent_app_type] => utility
[patent_app_number] => 18/389167
[patent_app_country] => US
[patent_app_date] => 2023-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 28
[patent_no_of_words] => 31060
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18389167
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/389167 | Emulsion formulations | Nov 12, 2023 | Issued |
Array
(
[id] => 19018872
[patent_doc_number] => 20240075043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => IMMEDIATE AND CONTROLLED RELEASE APPETITE SUPPRESSANT COMPOSITIONS FOR WEIGHT LOSS
[patent_app_type] => utility
[patent_app_number] => 18/501814
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501814
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/501814 | Immediate and controlled release appetite suppressant compositions for weight loss | Nov 2, 2023 | Issued |
| 18/386017 | (E)-1-(2-(4-SUBSTITUTEDPHENYL)-2-OXOETHYL)-4-((HYDROXYIMINO)METHYL)PYRIDINIUM BROMIDES AS ANTITUBERCULAR AGENTS | Oct 31, 2023 | Abandoned |
Array
(
[id] => 19001923
[patent_doc_number] => 20240065994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING DISEASES OR DISORDERS ASSOCIATED WITH PROTEIN MISFOLDING
[patent_app_type] => utility
[patent_app_number] => 18/494441
[patent_app_country] => US
[patent_app_date] => 2023-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18494441
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/494441 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING DISEASES OR DISORDERS ASSOCIATED WITH PROTEIN MISFOLDING | Oct 24, 2023 | Abandoned |
Array
(
[id] => 19279830
[patent_doc_number] => 20240216302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => METHODS OF ADMINISTERING SOLRIAMFETOL TO LACTATING WOMEN
[patent_app_type] => utility
[patent_app_number] => 18/491311
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491311
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491311 | Methods of administering solriamfetol to lactating women | Oct 19, 2023 | Issued |
Array
(
[id] => 19279831
[patent_doc_number] => 20240216303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => METHODS OF ADMINISTERING SOLRIAMFETOL TO LACTATING WOMEN
[patent_app_type] => utility
[patent_app_number] => 18/491319
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491319
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491319 | Methods of administering solriamfetol to lactating women | Oct 19, 2023 | Issued |
Array
(
[id] => 19279828
[patent_doc_number] => 20240216300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => METHODS OF ADMINISTERING SOLRIAMFETOL TO LACTATING WOMEN
[patent_app_type] => utility
[patent_app_number] => 18/491291
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491291
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491291 | Methods of administering solriamfetol to lactating women | Oct 19, 2023 | Issued |
Array
(
[id] => 19279829
[patent_doc_number] => 20240216301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => METHODS OF ADMINISTERING SOLRIAMFETOL TO LACTATING WOMEN
[patent_app_type] => utility
[patent_app_number] => 18/491301
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18491301
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/491301 | Methods of administering solriamfetol to lactating women | Oct 19, 2023 | Issued |
Array
(
[id] => 19691199
[patent_doc_number] => 20250009744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => USE OF METABOLIC REGULATORS FOR THE TREATMENT OF LIPOTOXICITY IN THE LUNGS
[patent_app_type] => utility
[patent_app_number] => 18/379033
[patent_app_country] => US
[patent_app_date] => 2023-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379033
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/379033 | USE OF METABOLIC REGULATORS FOR THE TREATMENT OF LIPOTOXICITY IN THE LUNGS | Oct 10, 2023 | Pending |
Array
(
[id] => 19032415
[patent_doc_number] => 20240082230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => LIQUID NIMODIPINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/484564
[patent_app_country] => US
[patent_app_date] => 2023-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18484564
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/484564 | Liquid nimodipine compositions | Oct 10, 2023 | Issued |
Array
(
[id] => 19417274
[patent_doc_number] => 20240293397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => THERAPEUTIC USES OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)PHENYL]PIPERAZINE
[patent_app_type] => utility
[patent_app_number] => 18/483780
[patent_app_country] => US
[patent_app_date] => 2023-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18483780
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/483780 | THERAPEUTIC USES OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)PHENYL]PIPERAZINE | Oct 9, 2023 | Abandoned |
Array
(
[id] => 18860158
[patent_doc_number] => 20230414592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => NON-AQUEOUS LIQUID NIMODIPINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/244168
[patent_app_country] => US
[patent_app_date] => 2023-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18244168
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/244168 | Non-aqueous liquid nimodipine compositions | Sep 7, 2023 | Issued |
Array
(
[id] => 19049241
[patent_doc_number] => 20240091210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => USE OF 5-[[4-[2-[5-ACETYLPYRIDIN-2-YL]ETHOXY]BENZYL]-1,3-THIAZOLIDINE-2,4-DIONE AND ITS SALTS
[patent_app_type] => utility
[patent_app_number] => 18/460197
[patent_app_country] => US
[patent_app_date] => 2023-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18460197
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/460197 | USE OF 5-[[4-[2-[5-ACETYLPYRIDIN-2-YL]ETHOXY]BENZYL]-1,3-THIAZOLIDINE-2,4-DIONE AND ITS SALTS | Aug 31, 2023 | Pending |
Array
(
[id] => 19909230
[patent_doc_number] => 12285415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Compositions for the treatment of hypertension
[patent_app_type] => utility
[patent_app_number] => 18/446268
[patent_app_country] => US
[patent_app_date] => 2023-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23366
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18446268
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/446268 | Compositions for the treatment of hypertension | Aug 7, 2023 | Issued |
Array
(
[id] => 20992345
[patent_doc_number] => 12740960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-22
[patent_title] => Treatment of herpes zoster with topical tetracaine
[patent_app_type] => utility
[patent_app_number] => 18/362522
[patent_app_country] => US
[patent_app_date] => 2023-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 855
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18362522
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/362522 | TREATMENT OF HERPES ZOSTER WITH TOPICAL TETRACAINE | Jul 30, 2023 | Pending |
Array
(
[id] => 18953517
[patent_doc_number] => 20240041844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => COMPOSITIONS AND METHODS FOR AMELIORATING HELICOBACTERACEAE INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/356182
[patent_app_country] => US
[patent_app_date] => 2023-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18356182
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/356182 | Compositions and methods for ameliorating | Jul 19, 2023 | Issued |
Array
(
[id] => 18901282
[patent_doc_number] => 20240016767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => METHOD OF VIRAL INHIBITION
[patent_app_type] => utility
[patent_app_number] => 18/355802
[patent_app_country] => US
[patent_app_date] => 2023-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18355802
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/355802 | Method of viral inhibition | Jul 19, 2023 | Issued |
Array
(
[id] => 20577236
[patent_doc_number] => 12569471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Method of treatment of CNS disorders
[patent_app_type] => utility
[patent_app_number] => 18/222681
[patent_app_country] => US
[patent_app_date] => 2023-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 0
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18222681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/222681 | Method of treatment of CNS disorders | Jul 16, 2023 | Issued |
Array
(
[id] => 18901336
[patent_doc_number] => 20240016821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => DRINK PRODUCT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/351368
[patent_app_country] => US
[patent_app_date] => 2023-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351368
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/351368 | DRINK PRODUCT AND USE THEREOF | Jul 11, 2023 | Pending |